Guillem Gonzalez-Lomas, MD
Sports Medicine · New York, NYNPI 1457510844
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $24,901 of the $41,102 with a category attached, or 60.6%. 17 manufacturers reported payments, led by Smith+Nephew at 48.8% of the total. 2025 is the largest year on record at $21,195, 4.0 times the $5,364 reported in 2019.
Across 81 payments — averaging $507.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$20K
- Arthrex$7K
- Depuy Synthes Products, Inc.$6K
- Gotham Surgical Solutions & Devices, Inc.$3K
- Suvon Surgical LLC$2K
- Vericel Corporation$2K
- plus $2K from 11 others
What the payments were for
- Consulting fees$24,90161%
- Speaking & faculty fees$4,00010%
- Travel & lodging$4,76012%
- Food & beverage$3,8429%
- Education$3,6009%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 15 | $20,049 |
| Arthrex | 37 | $7,227 |
| Depuy Synthes Products, Inc. | 2 | $6,088 |
| Gotham Surgical Solutions & Devices, Inc. | 4 | $2,845 |
| Suvon Surgical LLC | 5 | $1,697 |
| Vericel Corporation | 2 | $1,669 |
| Miach Orthopaedics, Inc. | 2 | $483 |
| Lifenet Health | 2 | $328 |
| Joint Restoration Foundation, Inc. | 1 | $289 |
| Stryker | 2 | $203 |
| KCI USA, Inc. | 1 | $75 |
| Astellas Pharma US Inc | 2 | $47 |
| Medical Device Business Services, Inc. | 2 | $32 |
| Antares Pharma, Inc. | 1 | $23 |
| Moximed, Inc | 1 | $20 |
| IBSA Pharma Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Q-FIX$19,095
- FAST-FIX$17,400
- SPATIAL FRAME$17,400
- ACUFEX Meniscal Root Repair$2,008
- CAP-FIX$1,695
- Healicoil$1,695
- NOVOSTITCH$1,695
- MACI$1,650
- Regeneten$261
- GraftLink TS$205
- Quadlink$205
- ARTHROPLASTY IMPLANTS REVERS TOTAL SHOULDER REVERS$125
- GraftLink$123
- Bone Anchors with Arthroscopic Delivery System$119
- Bioinductive Implant with Arthroscopic Delivery System - Medium$105
- Meniscal Root Repair System$105
- REGENESORB$105
- MICRORAPTOR Knotless Anchor$105
- Dyonics Platinum$105
How this compares
$41,102 in reported general payments places this provider in the 85th percentile of 403 sports medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 11 | $149 |
| Meloxicam | 29 | $81 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in New York
- Gregory DifeliceNew York$1.8M
- Theodore BlaineNew York$765K
- Robert MeislinNew York$720K
- Danyal NawabiNew York$592K
- Riley WilliamsNew York$512K
- Bryan KellyNew York$409K
- Samuel TaylorNew York$255K
- Eric StraussNew York$241K
- Michael FuNew York$210K
- Michael AlaiaNew York$207K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.